a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY

Clinical trial NCT04290611 · COMPLETED

Trial details

NCT number: NCT04290611
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer Neuropathy Epilepsy Encephalopathy

Start date: 2019-01-01
Primary completion: 2023-01-01
Enrollment: 500000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.